Application of lymphoplasmapheresis in the treatment of severe myasthenia gravis

Application of lymphoplasmapheresis in the treatment of severe myasthenia gravis

BackgroundLymphoplasmapheresis (LPE) is a treatment that combines traditional plasma exchange and lymphocyte removal technique. It has been applied to treat a variety of autoimmune diseases, but its application value in the treatment of severe myasthenia gravis (MG) is not yet clear. Therefore, the...

Full description

Bibliographic Details
Main Authors: Weiwei Duan, Hao Zhou, Xiaohua Dong, Bijuan Li, Yi Li, Haobing Cai, Qian Zhou, Song Ouyang, Weifan Yin, Huan Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Neurology
Subjects:
myasthenia gravis
lymphoplasmapheresis
immunotherapy
efficacy
safety
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.1018509/full

Similar Items

Similar Items